- Home
- KRRO vs EHAB Comparison
KRRO vs EHAB Comparison
Compare KRRO & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- EHAB
- Stock Information
- Founded
- KRRO 2014
- EHAB 2014
- Country
- KRRO United States
- EHAB United States
- Employees
- KRRO N/A
- EHAB N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- EHAB Hospital/Nursing Management
- Sector
- KRRO Health Care
- EHAB Health Care
- Exchange
- KRRO Nasdaq
- EHAB Nasdaq
- Market Cap
- KRRO 358.3M
- EHAB 403.5M
- IPO Year
- KRRO 2019
- EHAB N/A
- Fundamental
- Price
- KRRO $38.88
- EHAB $8.54
- Analyst Decision
- KRRO Strong Buy
- EHAB Buy
- Analyst Count
- KRRO 7
- EHAB 3
- Target Price
- KRRO $96.71
- EHAB $8.67
- AVG Volume (30 Days)
- KRRO 241.5K
- EHAB 316.8K
- Earning Date
- KRRO 11-12-2025
- EHAB 11-05-2025
- Dividend Yield
- KRRO N/A
- EHAB N/A
- EPS Growth
- KRRO N/A
- EHAB N/A
- EPS
- KRRO N/A
- EHAB N/A
- Revenue
- KRRO $6,281,000.00
- EHAB $1,037,800,000.00
- Revenue This Year
- KRRO $116.91
- EHAB $4.95
- Revenue Next Year
- KRRO N/A
- EHAB $4.51
- P/E Ratio
- KRRO N/A
- EHAB N/A
- Revenue Growth
- KRRO N/A
- EHAB N/A
- 52 Week Low
- KRRO $10.29
- EHAB $6.47
- 52 Week High
- KRRO $76.79
- EHAB $10.91
- Technical
- Relative Strength Index (RSI)
- KRRO 47.86
- EHAB 59.14
- Support Level
- KRRO $38.02
- EHAB $8.42
- Resistance Level
- KRRO $40.97
- EHAB $8.72
- Average True Range (ATR)
- KRRO 4.85
- EHAB 0.28
- MACD
- KRRO -1.42
- EHAB 0.02
- Stochastic Oscillator
- KRRO 12.27
- EHAB 74.77
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.